Search

Thousands of clinicians, scientists, researchers and innovators from around the world will gather together Wednesday, May 9 through Saturday, May 12 at the Boston Convention and Exhibition Center for Heart Rhythm 2018, the Heart Rhythm Society’s (HRS) 39th Annual Scientific Sessions, to explore recent developments in the field of cardiac pacing and electrophysiology (EP). The meeting will start with a keynote address by Sherry Turkle who will challenge attendees to think about how technological advancements not only catalyze change but affect ways of thinking. 

According to new research, smoking marijuana may not be associated with an increased risk of ventricular fibrillation (VF) and ventricular tachycardia (VT) following an acute myocardial infarction (AMI), or heart attack. The study also reported that marijuana users had a decreased risk of atrial fibrillation (AFib) and in-hospital mortality. The results are scheduled to be presented on Thursday, May 10 at Heart Rhythm 2018, the Heart Rhythm Society’s 39th Annual Scientific Sessions.

A new study is the first to report a relationship between post-traumatic stress disorder (PTSD) and new cases of atrial fibrillation (AF), the most common heart arrhythmia. The large nationwide study included more than 1 million patients with no prior history of AF or atrial flutter. The study is scheduled to be presented on Friday, May 11 at Heart Rhythm 2018, the Heart Rhythm Society’s 39th Annual Scientific Sessions.

A new study shows that women exposed to particular matter (PM) and lower temperatures for even a short amount of time are at an increased risk of sudden cardiac death (SCD). PM is a mixture of hazardous, small particle pollutants that includes dust, pollen, soot, smoke and liquid droplets that get into the air. The study is the largest of its kind in the United States to date and is scheduled to be presented on Wednesday, May 9 at Heart Rhythm 2018, the Heart Rhythm Society’s 39th Annual Scientific Sessions.

A new study is the first to validate the accuracy of wrist-worn wearable devices in measuring induced paroxysmal supraventricular tachycardia (PSVT), or episodes of rapid heart rate. Three common wearable devices including the Apple Watch Series 2, Samsung Galaxy Gear S3 and the Fitbit Charge 2, were randomly assigned to patients to measure heart rate. The results of this study are scheduled to be presented on Friday, May 11 at Heart Rhythm 2018, the Heart Rhythm Society’s 39th Annual Scientific Sessions.  

January 2003—The provision of services accompanying technology-based electrophysiological-related interventions created an opportunity for health care professionals to specialize in the field of cardiac rhythm management. Known as allied professionals (APs), this diverse group of nurses, physician assistants, technologists, technicians, and engineers is dedicated to promoting excellence in the care of patients with cardiac rhythm disorders.

This document was reaffirmed on February 7, 2018, and will be formally assessed by February 2023.

February 2002—This Statement gives the revised NBG code, endorsed by the British Pacing and Electrophysiology Group (BPEG) and the North American Society of Pacing and Electrophysiology (NASPE, now known as Heart Rhythm Society) in 2001. This statement is more compatible with contemporary and emerging pacing technology with particular attention to the issue of multisite pacing.

This document was reaffirmed on February 7, 2018, and will be formally assessed by February 2023.

August 2011—Genetic testing is increasingly important in determining potential cardiac conditions in patients and is used in clinical settings more than ever before. To ensure that physicians have up-to-date knowledge of the evolving role of genetic testing for sudden death predisposing, genetic heart diseases in cardiology, which can be lifesaving for some patients, the Heart Rhythm Society and the European Heart Rhythm Association have prepared HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies

This document was reaffirmed on April 11, 2018, and will be formally assessed by April 2023.

July 2011—Developed as a joint project with the American Society of Anesthesiologists (ASA), and in collaboration with the American Heart Association (AHA) and the Society of Thoracic Surgeons (STS), a diverse panel of experts in pacemaker and defibrillator management focused on medical procedures that might interfere with cardiovascular implantable electronic devices (CIEDs) function.

This document was reaffirmed on March 7, 2018, and will be formally assessed by March 2021.